Gail Miflin

2.1k total citations
18 papers, 367 citations indexed

About

Gail Miflin is a scholar working on Hematology, Management of Technology and Innovation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gail Miflin has authored 18 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Management of Technology and Innovation and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gail Miflin's work include Blood donation and transfusion practices (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Organ Donation and Transplantation (4 papers). Gail Miflin is often cited by papers focused on Blood donation and transfusion practices (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Organ Donation and Transplantation (4 papers). Gail Miflin collaborates with scholars based in United Kingdom, Netherlands and Switzerland. Gail Miflin's co-authors include C Stainer, NH Russell, Nigel H. Russell, Jenny Byrne, Sally A. Anderson, Ann Hunter, A. P. Haynes, Gavin Cull, G Hale and Antonio Pagliuca and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Gail Miflin

18 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gail Miflin United Kingdom	11	275	93	84	82	52	18	367
C Stainer United Kingdom	11	282 1.0×	90 1.0×	84 1.0×	122 1.5×	49 0.9×	12	384
Diane S. Sempek United States	6	323 1.2×	66 0.7×	66 0.8×	143 1.7×	57 1.1×	7	397
GR Morgenstern United Kingdom	9	327 1.2×	28 0.3×	60 0.7×	185 2.3×	22 0.4×	10	441
Corentin Orvain France	11	233 0.8×	76 0.8×	124 1.5×	53 0.6×	71 1.4×	59	384
Ding‐Ping Chen Taiwan	11	150 0.5×	99 1.1×	25 0.3×	40 0.5×	13 0.3×	54	403
Dawn Maze Canada	10	220 0.8×	42 0.5×	128 1.5×	41 0.5×	46 0.9×	62	370
Ozan Salim Türkiye	11	84 0.3×	49 0.5×	65 0.8×	52 0.6×	24 0.5×	46	271
Sara Mach‐Pascual Switzerland	9	218 0.8×	73 0.8×	161 1.9×	25 0.3×	18 0.3×	12	362
Karl‐Walter Sykora Germany	4	155 0.6×	174 1.9×	67 0.8×	49 0.6×	36 0.7×	5	281
Eric Beohou France	12	247 0.9×	37 0.4×	39 0.5×	144 1.8×	95 1.8×	18	385

Countries citing papers authored by Gail Miflin

Since Specialization

Citations

This map shows the geographic impact of Gail Miflin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Miflin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Miflin more than expected).

Fields of papers citing papers by Gail Miflin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Miflin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Miflin. The network helps show where Gail Miflin may publish in the future.

Co-authorship network of co-authors of Gail Miflin

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Miflin. A scholar is included among the top collaborators of Gail Miflin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Miflin. Gail Miflin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Thomas, Stephen, Koen Kramer, Françoise Rossi, et al.. (2023). Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variantCreutzfeldt–Jakobdisease. Vox Sanguinis. 118(5). 345–353. 3 indexed citations

Kim, Lois G., Thomas Bolton, Michael Sweeting, et al.. (2023). Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study. Transfusion. 63(3). 541–551. 3 indexed citations

Sadique, Zia, Sarah Willis, Mark Pennington, et al.. (2022). Cost-effectiveness of alternative minimum recall intervals between whole blood donations. PLoS ONE. 17(8). e0272854–e0272854. 1 indexed citations

Allard, Shubha, et al.. (2021). Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England. Transfusion Medicine. 31(6). 400–408. 2 indexed citations

Bell, Steven, Michael Sweeting, Anna Ramond, et al.. (2020). Comparison of four methods to measure haemoglobin concentrations in whole blood donors ( COMPARE ): A diagnostic accuracy study. Transfusion Medicine. 31(2). 94–103. 11 indexed citations

Grieve, Richard, Sarah Willis, Zia Sadique, et al.. (2018). Options for possible changes to the blood donation service: health economics modelling. SHILAP Revista de lepidopterología. 6(40). 1–162. 6 indexed citations

Willis, Sarah, John Cairns, Zia Sadique, et al.. (2018). Cost‐effectiveness of alternative changes to a national blood collection service. Transfusion Medicine. 29(S1). 42–51. 2 indexed citations

Moore, Carmel, Thomas Bolton, Matthew R. Walker, et al.. (2016). Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals. Trials. 17(1). 458–458. 13 indexed citations

Rice, Claire M, David I. Marks, Yoav Ben‐Shlomo, et al.. (2015). Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial. Trials. 16(1). 463–463. 30 indexed citations

10.

Miflin, Gail & S. E. Kinsey. (2003). Management of infection in children with malignancy. European Journal of Cancer. 39(5). 644–651. 1 indexed citations

11.

Cull, Gavin, A. P. Haynes, Jenny Byrne, et al.. (2000). Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH conditioning: an effective regimen with low procedure‐related toxicity. British Journal of Haematology. 108(4). 754–760. 59 indexed citations

12.

Miflin, Gail, NH Russell, Ian M. Franklin, et al.. (2000). An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation. Cytotherapy. 2(6). 423–428. 11 indexed citations

13.

Miflin, Gail, et al.. (1999). Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow. British Journal of Haematology. 107(2). 429–440. 18 indexed citations

14.

Stainer, C, et al.. (1998). A Comparison of Two Different Systems for CD34+ Selection of Autologous or Allogeneic PBSC Collections. Journal of Hematotherapy. 7(4). 375–383. 22 indexed citations

15.

Byrne, Jenny, et al.. (1998). Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis. Bone Marrow Transplantation. 22(6). 541–545. 19 indexed citations

16.

Miflin, Gail, NH Russell, R. M. Hutchinson, et al.. (1997). Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplantation. 19(1). 9–13. 75 indexed citations

17.

Russell, NH, Gail Miflin, C Stainer, et al.. (1997). Allogeneic Bone Marrow Transplant for Multiple Myeloma. Blood. 89(7). 2610–2610. 24 indexed citations

18.

Miflin, Gail, et al.. (1996). STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACY. British Journal of Haematology. 95(2). 345–348. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact